What to check

  • Grand View Research publicly reports Australia peptide therapeutics revenue of US$1.906B in 2025 and a US$3.711B 2033 forecast.
  • McDermott's April 2026 peptide presentation cites global peptide therapeutics growth from US$140.86B in 2025 to US$294.58B by 2033.
  • TIME and NPR both report mainstream social-media and influencer attention around peptides in 2026.
  • The Week and GZERO report US hormone and peptide compound imports from China nearly doubled to US$328M in the first three quarters of 2025.
  • The lesson for Peptide Checker: make every growth story resolve back to proof, not hype.

The fastest safe path is still the same: batch, COA, label, payment, support, and dispatch proof before trust.

Run the batch checker